Support our Foundation of Myology project
1722 news items
Neurodevelopment and mental health in children with symptomatic or presymptomatic SMA
On 15/10/2025
Italian clinicians undertook a large neuropsychological and neurobehavioural study in children with SMN1-related proximal spinal muscular atrophy (SMA) type 1 who had received innovative therapy…
An atypical case of acetyl-CoA dehydrogenase deficiency reported in France
On 14/10/2025
Clinicians at Caen University Hospital and Necker-Enfants Malades Hospital in Paris report the case of a 33-year-old female patient whose history was confusing in several…
Two young researchers from the Institute awarded at WMS and ESGCT conferences
On 13/10/2025
Two young researchers, a PhD student and a postdoctoral fellow, from the Muscle organization & therapy of dominant centronuclear myopathy team co-led by Marc Bitoun…
Researchers from the institute attending the MYO-MRI+ conference
On 13/10/2025
The 5th International Imaging in Neuromuscular Disease Conference organised by the MYO-MRI+ consortium will be held in Berlin, Germany, from 9 to 11 November 2025.…
A look back at the Institute’s Fête de la Science
On 13/10/2025
On Monday 6 and Tuesday 7 October, we had the pleasure of welcoming 80 visitors at the Institute of Myology for “Fête de la Science”…
Neurodevelopmental disorders quantified in DMD
On 13/10/2025
While the impact of Duchenne muscular dystrophy (DMD) on patients’ cognition is well known, an Italian team focused specifically on the prevalence of neurodevelopmental disorders…
The added value of artificial intelligence in myasthenia gravis remains to be confirmed
On 10/10/2025
Taiwanese researchers conducted an exhaustive analysis of the literature on artificial intelligence (AI) tools in the context of predictive factors at certain stages of myasthenia…
ERN EURO-NMD webinar, 16 Oct. : Pr Antonio Toscano (Italy)
On 09/10/2025
Management of HyperCKemia Thursday 16 October 2025 – 16:00 – 17:00 Paris time Prof. Antonio Toscano (University of Messina, Italy) > + infos Organized…
An alternative to statin use in cases of immune-mediated necrotising myopathy
On 09/10/2025
Italian clinicians report the results of a study on the use of a new molecule, bempedoic acid, which has lipid-lowering properties but does not carry…
A case immune-mediated necrotising myopathy associated with tuberculosis
On 08/10/2025
An Italian team reports a case of autoimmune necrotising myopathy occurring in the context of active tuberculosis in a 38-year-old migrant: the patient, originally from…
Case report of DNAJB4-related myopathy in France
On 07/10/2025
Myologists from the Paris region, including an expert from the Institute, report the case of a patient with an ultra-rare myopathy: the clinical picture combined…
Three case reports suggest the efficacy of eculizumab in dermatomyositis and myasthenic crisis
On 06/10/2025
Already indicated for refractory forms of myasthenia gravis, eculizumab (Soliris®) has been shown to be effective in two other indications: French clinicians, including experts from…
A plea for neonatal screening for DMD
On 06/10/2025
In a comprehensive article, American specialists analyse practices and prospects for newborn screening for Duchenne muscular dystrophy in the United States: this screening is technically…
Improvement in motor function with Evrysdi® in presymptomatic SMA
On 03/10/2025
Approved for spinal muscular atrophy (SMA), the efficacy of Evrysdi® in presymptomatic forms remained uncertain. In the international RAINBOWFISH open-label trial, 26 genetically diagnosed infants…
Long-term IV immunoglobulins may reduce the incidence of cancer
On 02/10/2025
According to an analysis of follow-up data from 436 patients with autoimmune myasthenia gravis (MG) and 102 with chronic inflammatory demyelinating polyradiculoneuritis (CIDP), receiving intravenous…
The SMA France Registry for collecting real-life or long-term data
On 01/10/2025
As of 22 July 2024, the SMA France Registry had collected data from 1,259 people with spinal muscular atrophy (SMA) through 59 participating reference centres,…
Immunomodulatory mesenchymal cells useful in myasthenia gravis
On 01/10/2025
A group of researchers coordinated by the Institute of Myology has focused on a small contingent of cells and their potential use in the treatment…
Sustainable cardioprotection with utrophin in DMD
On 30/09/2025
Scientists have evaluated a gene therapy based on micro-utrophin, a protein similar to dystrophin, which is deficient in Duchenne muscular dystrophy (DMD). This therapy was…
LGMD Awareness Day: 30 September
On 29/09/2025
The 11th Limb Girdle Muscular Dystrophy Awareness Day takes place on 30 September. Organised by the LGMD Awareness Foundation, the aim of this day is…
Mitochondrial abnormalities, a possible marker of unfavourable progression in inflammatory myopathies
On 29/09/2025
The presence of mitochondrial abnormalities is now a criterion for the diagnosis of sporadic inclusion myositis. It is also a predictive marker of progression in…
